Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Hair loss from telogen effluvium can cause mental health issues and lower life quality, needing both medical and emotional support.

Hair shedding that lasts over 6 months may need a closer look, but often just reassurance is enough.

Telogen effluvium is a common, distressing condition causing excessive hair shedding and has significant psychological effects on patients.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Many drugs can cause hair loss.

COVID-19 has increased hair loss, but many patients see regrowth within months.

The author suggests changing "telogen effluvium" to "telogen defluxion" for hair loss terminology.

Pigtail hair is a sign of new hair growth and should be recognized in hair loss conditions like acute telogen effluvium.

Hair loss at the site where hair was taken for a transplant can be due to the normal hair growth cycle.

Hair shedding that lasts more than 6 months may need medical tests, but often just reassurance is enough.

Post-COVID-19 hair loss is likely due to stress and inflammation.

Most children with rapid hair loss had a known cause, with stress and illness being top triggers, and treatments showed similar improvement.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

The document concludes that we need more research to understand Telogen Effluvium and find effective treatments.

COVID-19 can cause temporary hair loss.

A horse's sudden hair loss was caused by an allergic reaction to a coat conditioning powder.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

Anesthesia and surgery can cause temporary hair loss, but hair usually grows back without treatment.

Most Iraqi women with telogen effluvium did not have a clear cause for their hair loss, and few had significant thinning.

Critically ill patients may experience temporary hair loss after a fever.

Some drugs can cause temporary or permanent hair loss.

A 17-year-old girl has had repeated hair loss since childhood, which can be triggered by infections like COVID-19.

Most Iraqi women with telogen effluvium had no clear cause for their hair loss, and few had significant thinning.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Modern therapies, like fractional laser, effectively treat telogen effluvium.

COVID-19 may cause hair loss months after infection.

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.

The debate focuses on the role of catagen and hair shedding mechanisms in telogen effluvium.